Context Therapeutics (6K9.F) Q2 2024 Earnings

8MayConfirmed
Q2 2024
-0.41
-0.34
-0.28
-0.21

Details

Expected EPS
-0.40933200000000003
Actual EPS
-0.21396900000000002
Surprise EPS
0.2
Surprise Percent
+47.73%

Description

Context Therapeutics (6K9.F) has reported earnings of -0.21396900000000002 per share for Q2 2024.

0 Comments

Share your thoughts